Antigenic diversity ofNeisseria meningitidisisolated in Taiwan between 1995 and 2002
- 1 January 2006
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 38 (4) , 273-280
- https://doi.org/10.1080/00365540500440379
Abstract
The geographic distribution of N. meningitidis is diverse. Information on the antigenic variation of N. meningitidis is important for the development of an outer membrane protein-based vaccine. As a first step towards vaccine development, serological typing was performed to determine the antigenic properties of 127 invasive N. meningitidis isolates collected in Taiwan between 1995 and 2002. With 31.5% non-serotypeable and 32.3% non-serosubtypeable, the 127 isolates fell into 51 phenotypes, with W135:NT:P1.5,2:L3,7,9, Y:14P1.5,2, and B:1:NST:L3,7,9 being the 3 most prevalent. Among the 37 serogroup B isolates, 15 serosubtypes were found, with P1.5,2 and P1.12,13 being the most prevalent. The high diversity of Por A among serogroup B isolates circulating in Taiwan poses a great challenge for the development of a PorA-based vaccine. Because 85% of the serogroup B isolates had the L3,7,9 immunotype, inclusion of L3,7,9 lipooligosaccharides in a PorA-based vaccine may be a promising approach. In addition, based on the phenotypic characterization, we suggest that both serogroup B and W135 isolates were endemic and that serogroup A, C, and Y isolates were imported, which may reflect increased international travel.Keywords
This publication has 31 references indexed in Scilit:
- Distribution of Surface Protein Variants among Hyperinvasive Meningococci: Implications for Vaccine DesignInfection and Immunity, 2004
- First Report of Capsule Replacement among Electrophoretic Type 37 Neisseria meningitidis Strains in ItalyJournal of Clinical Microbiology, 2003
- Immunization with the Recombinant PorB Outer Membrane Protein Induces a Bactericidal Immune Response against Neisseria meningitidisInfection and Immunity, 2002
- Meningococcal VaccinesInfectious Disease Clinics of North America, 2001
- Peptide mimics elicit antibody responses against the outer-membrane lipooligosaccharide of group BNeisseria meningitidisFEMS Microbiology Letters, 2000
- Rapid Serogroup Switching inNeisseria meningitidisNew England Journal of Medicine, 2000
- Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccineVaccine, 1996
- Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccineVaccine, 1996
- The maintenance of strain structure in populations of recombining infectious agentsNature Medicine, 1996
- Antigenic and Epidemiologic Properties of the ET-37 Complex of Neisseria meningitidisThe Journal of Infectious Diseases, 1993